ZAI LAB LTD-ADR(NASDAQ:ZLAB) stock News

ZLAB Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Yahoo Finance - Mentions: GS BAC 9688 AMGN

Zai Lab Ltd (ZLAB) Delivers Positive Results for Potential Gastric Cancer Treatment

9 days ago - By: Benzinga - Mentions: NAK NFLX SRPT GNLN ...

Netflix, BlackSky Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session

3 months ago - By: Benzinga - Mentions: MSC ELUT ACIW JYNT ...

Earnings Scheduled For May 8, 2025

17 days ago - By: Zai Lab Limited

Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on August 7, 2025

a month ago - By: Zai Lab Limited

Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-Line Gastric Cancer

a month ago - By: Yahoo Finance - Mentions: VRNA

Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis

a month ago - By: Zai Lab Limited

Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025

2 months ago - By: Zai Lab Limited

Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO Annual Meeting

2 months ago - By: Zai Lab Limited

Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting

2 months ago - By: Zai Lab Limited

Zai Lab Announces Participation in Investor Conferences in June 2025

2 months ago - By: Zai Lab Limited

Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conjugate, for Treatment of Extensive-Stage Small Cell Lung Cancer

3 months ago - By: Zacks Investment Research

Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say

3 months ago - By: Zai Lab Limited

Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates

3 months ago - By: Yahoo Finance - Mentions: MTRX BX GS DDOG ...

Matrix Service Company (MTRX): Among the Best Breakout Stocks to Buy According to Analysts

3 months ago - By: Yahoo Finance - Mentions: BX GS MTRX DDOG ...

Zai Lab Limited (ZLAB): Among the Best Breakout Stocks to Buy According to Analysts

3 months ago - By: Yahoo Finance - Mentions: GOGO BX GS MTRX ...

Gogo Inc. (GOGO): Among the Best Breakout Stocks to Buy According to Analysts

3 months ago - By: Yahoo Finance - Mentions: GEHC GE BX GS ...

Is GE HealthCare Technologies (GEHC) A Hidden AI Stock to Buy Right Now?

3 months ago - By: Yahoo Finance - Mentions: MELI DB BLK FCX ...

Is MercadoLibre, Inc. (MELI) One of the High Growth Companies Hedge Funds Are Buying?

3 months ago - By: Zai Lab Limited

Zai Lab Presents Data Highlighting Potential of Internally Developed, Next-Generation Oncology Therapies at AACR 2025

3 months ago - By: Zai Lab Limited

Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 at 2025 ASCO Annual Meeting

3 months ago - By: Zai Lab Limited

Zai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients with NTRK-Positive Solid Tumors

3 months ago - By: Yahoo Finance - Mentions: NVS JNJ BIDU CXDO ...

J&J projects $400m tariff hit but raises sales outlook

3 months ago - By: Zai Lab Limited

Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2025

4 months ago - By: Yahoo Finance - Mentions: SMMT PFE WMT

Why Summit Therapeutics Inc. (SMMT) Went Up On Thursday?

4 months ago - By: Yahoo Finance - Mentions: JPM TSLA

Zai Lab Limited (ZLAB): Among Stocks Insiders Sold in April After Trump’s Tariff Rollout

4 months ago - By: Zai Lab Limited

ZAI LAB LTD-ADR (ZLAB) Stock News

ZLAB Latest News, Press Relases and Analysis

Zai Lab Ltd (ZLAB) Delivers Positive Results for Potential Gastric Cancer Treatment

Netflix, BlackSky Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Earnings Scheduled For May 8, 2025

Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on August 7, 2025

Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-Line Gastric Cancer

Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis

Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025

Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO Annual Meeting

Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting

Zai Lab Announces Participation in Investor Conferences in June 2025

Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conjugate, for Treatment of Extensive-Stage Small Cell Lung Cancer

Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say

Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates

Matrix Service Company (MTRX): Among the Best Breakout Stocks to Buy According to Analysts

Zai Lab Limited (ZLAB): Among the Best Breakout Stocks to Buy According to Analysts

Gogo Inc. (GOGO): Among the Best Breakout Stocks to Buy According to Analysts

Is GE HealthCare Technologies (GEHC) A Hidden AI Stock to Buy Right Now?

Is MercadoLibre, Inc. (MELI) One of the High Growth Companies Hedge Funds Are Buying?

Zai Lab Presents Data Highlighting Potential of Internally Developed, Next-Generation Oncology Therapies at AACR 2025

Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 at 2025 ASCO Annual Meeting

Zai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients with NTRK-Positive Solid Tumors

J&J projects $400m tariff hit but raises sales outlook

Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2025

Why Summit Therapeutics Inc. (SMMT) Went Up On Thursday?

Zai Lab Limited (ZLAB): Among Stocks Insiders Sold in April After Trump’s Tariff Rollout

Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting